Over a dozen Senate Democrats urged President-elect Donald Trump to tackle high prescription drug costs and suggested in a letter Tuesday (Dec. 20) that upcoming FDA user fee bills offer an “ample opportunity” for him to do so. The letter, spearheaded by Sens. Sherrod Brown (D-OH) and Al Franken (D-MN), calls for Trump to work with Congress to allow HHS to negotiate drug prices, increase drug price transparency and stop brand drug companies from blocking “generic competitors from bringing their...